Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.40    -0.25 (-3.27%)
Bid:
7.30
Ask:
7.50
Spread: 0.20 (2.74%)
Market Cap: £3.24m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Circ re. EGM

28 Feb 2005 17:04

Feedback PLC28 February 2005 FEEDBACK PLC 28 FEBRUARY 2005 Feedback plc Extraordinary general meeting to be convened pursuant to section 142 Companies Act 1985 As the net assets of Feedback plc (the "Company") are presently less than halfof its called up share capital, the Directors are obliged by section 142 of theCompanies Act 1985 to convene an extraordinary general meeting ("EGM") of theCompany for the purpose of considering whether any, and if so what, steps shouldbe taken to deal with this situation. There has been a continuing diminution in the net assets of the Company inrecent years, as evidenced in the annual accounts for the year ended 31 March2004 and the interim results for the six months to 30 September 2004. This has arisen as a result of a combination of factors, including tradinglosses, necessary provisions made in respect of the Company's now closed definedbenefit scheme and a loss on the sale of the Company's former subsidiary,Teknical Limited. In addition, management accounts for the 4 months to January 2005 show thatthere has been a further diminution in assets since 30 September 2004 and afurther additional pension charge. As a result the Company's net assets have fallen to less than half of itscalled-up share capital. The Directors have been concerned about the financial position of the Companyand its subsidiaries (the "Group") and have referred to this, in particular, inthe interim statement to 30 September 2004 and at the annual general meetinglast year. Matters which have received attention are: (1) As announced on 24 February 2005, the Occupational Pensions RegulatoryAuthority has agreed to extend the period in which the shortfall in the pensionfund can be addressed. As a result of this the Company can reduce its annualcontributions to the pension scheme by over £600,000 to £521,400. (2) A loan of US$1,000,000 from Mr T Charlton, a former non-executivedirector, has been renegotiated, deferring repayment until 30 September 2009. (3) A long term solution depends upon a sustainable improvement in the levelof turnover and the associated cost structure. To achieve this, the board ofdirectors has undertaken a reorganisation of the sales function across theGroup, reorganised the internal reporting structure and reduced staff numbers.A review of the Group's property requirements and associated costs is at anadvanced stage, with the aim of providing the most appropriate facilities forthe Group's business whilst reducing costs. The circular convening the EGM to be held on Thursday 24th March 2005 at 11.00a.m. has today been posted to shareholders and copies are available from theCompany's registered office. Enquiries: David Sawyer 01892 653322 Chief Executive Feedback plc Philip Davies Charles Stanley & Co. Limited 020 7953 2457 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Oct 20217:00 amRNSPilot Scheme with Sussex Integrated Care System
11th Oct 20217:00 amRNSMOU with Quest Teleradiology
29th Sep 20217:00 amRNSFeedback Joins NHS AI Procurement Framework
23rd Sep 20217:00 amRNSOfficial Launch of Bleepa Box
14th Sep 20217:00 amRNSMemorandum of Understanding with Qure.ai
9th Sep 20217:00 amRNSLaunch of CareLocker to enhance Bleepa technology
25th Aug 20217:00 amRNSChange of Adviser
3rd Aug 20217:00 amRNSDigital Health article highlights Bleepa potential
16th Jul 20217:00 amRNSBleepa agreement with CVS Equine Division
5th Jul 202110:17 amRNSHolding(s) in Company
30th Jun 20213:30 pmRNSBoard Update
29th Jun 20217:00 amRNSUK Medical Device Certification for Bleepa
10th Jun 20217:00 amRNSBleepa available on Apple App Store & Google Play
8th Jun 20217:00 amRNSYear End Trading Update
6th May 20217:00 amRNSExecutive Appointment
24th Mar 20217:00 amRNSRoyal Berkshire NHS Foundation Trust Contract
23rd Feb 20217:00 amRNSHalf-year Report
19th Jan 20217:00 amRNSBleepa builds on robust data management security
4th Dec 20207:00 amRNSBleepa to join DIT’s first virtual event to India
10th Nov 20209:06 amRNSSelected for Digitalhealth.London 2020 Programme
6th Nov 20203:03 pmRNSResult of Annual General Meeting - Amendment
6th Nov 20201:50 pmRNSHolding(s) in Company
5th Nov 20201:23 pmRNSResult of AGM
5th Nov 20207:01 amRNSBleepa selected for WISH 2020 Innovation Awards
5th Nov 20207:00 amRNSAGM Statement
28th Oct 20203:10 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSBleepa adds 3D Imaging with Axial3D Partnership
13th Oct 20207:00 amRNSFinal Results
26th Aug 20201:34 pmRNSHolding(s) in Company
7th Aug 20207:00 amRNSDirector/PDMR Shareholding
5th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jul 20203:48 pmRNSBleepa appointed to major NHSx framework
29th Jul 20202:06 pmRNSSecond Price Monitoring Extn
29th Jul 20202:00 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSAppointment of Non-Executive Director
10th Jul 20207:00 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 202011:01 amRNSHolding(s) in Company
6th Jul 202010:36 amRNSHolding(s) in Company
6th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 20207:00 amRNSHolding(s) in Company
1st Jul 202012:46 pmRNSResult of Open Offer and General Meeting
25th Jun 202011:59 amRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSPlacing, Open Offer and Notice of GM
1st Jun 20207:00 amRNSBleepa® achieves CE Mark
21st May 20207:00 amRNSPapworth NHS Hosp - contract renewal with Bleepa
29th Apr 20202:05 pmRNSSecond Price Monitoring Extn
29th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Apr 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.